mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.04 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |